Serum Institute of India (SII) and Symbiosis International University (SIU) have signed a Memorandum of Understanding (MoU) in Pune to set up an early research centre for vaccines and biologicals.

The R&D centre will lead the development of new vaccines, technologies, products, and innovations in immunization practices that provide equitable access to life-saving interventions, especially across Low-and middle-income countries (LMIC’s). 

SII will help set up an early R&D facility within the Symbiosis campus at Lavale, Pune. The research centre will build and harness commitment to action by identifying opportunities that strengthen, to establish global immunisation agenda in pursuit of universal health coverage.

It will also ensure cross-programme coordination and collaboration, as the facility will be an ecosystem that also has R&D centres for stem cells, nanotechnology, medical image analysis, Applied AI, waste resource management among others.